Burrows Scott L 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Burrows Scott L（CIK 1853327）在 1 家公司共报告 37 笔 SEC Form 4 内部人交易（最近一笔 2026-10-02）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-10-02 | Spyre Therapeutics, Inc. (SYRE) | Chief Financial Officer | 买入 | 17,500 | $253,750 |
| 2026-10-02 | Spyre Therapeutics, Inc. (SYRE) | Chief Financial Officer | 卖出 | 17,500 | $1.6M |
| 2026-10-02 | Spyre Therapeutics, Inc. (SYRE) | Chief Financial Officer | 买入 | 7,500 | $108,750 |
| 2026-10-02 | Spyre Therapeutics, Inc. (SYRE) | Chief Financial Officer | 卖出 | 600 | $53,442 |
| 2026-10-02 | Spyre Therapeutics, Inc. (SYRE) | Chief Financial Officer | 卖出 | 1,500 | $135,405 |
| 2026-10-02 | Spyre Therapeutics, Inc. (SYRE) | Chief Financial Officer | 卖出 | 2,100 | $193,032 |
| 2026-10-02 | Spyre Therapeutics, Inc. (SYRE) | Chief Financial Officer | 卖出 | 3,071 | $285,449 |
| 2026-10-02 | Spyre Therapeutics, Inc. (SYRE) | Chief Financial Officer | 卖出 | 229 | $21,428 |
| 2026-09-03 | Spyre Therapeutics, Inc. (SYRE) | Chief Financial Officer | 卖出 | 200 | $17,808 |
| 2026-09-03 | Spyre Therapeutics, Inc. (SYRE) | Chief Financial Officer | 卖出 | 900 | $77,625 |
| 2026-09-03 | Spyre Therapeutics, Inc. (SYRE) | Chief Financial Officer | 卖出 | 4,384 | $381,890 |
| 2026-09-03 | Spyre Therapeutics, Inc. (SYRE) | Chief Financial Officer | 卖出 | 2,016 | $177,468 |
| 2026-09-03 | Spyre Therapeutics, Inc. (SYRE) | Chief Financial Officer | 买入 | 7,500 | $108,750 |
| 2026-09-03 | Spyre Therapeutics, Inc. (SYRE) | Chief Financial Officer | 卖出 | 18,232 | $1.6M |
| 2026-08-05 | Spyre Therapeutics, Inc. (SYRE) | Chief Financial Officer | 买入 | 7,500 | $108,750 |
| 2026-08-05 | Spyre Therapeutics, Inc. (SYRE) | Chief Financial Officer | 卖出 | 5,100 | $485,571 |
| 2026-08-05 | Spyre Therapeutics, Inc. (SYRE) | Chief Financial Officer | 卖出 | 2,300 | $221,490 |
| 2026-08-05 | Spyre Therapeutics, Inc. (SYRE) | Chief Financial Officer | 卖出 | 100 | $9,710 |
| 2026-07-02 | Spyre Therapeutics, Inc. (SYRE) | Chief Financial Officer | 买入 | 7,500 | $108,750 |
| 2026-07-02 | Spyre Therapeutics, Inc. (SYRE) | Chief Financial Officer | 卖出 | 5,775 | $505,601 |
| 2026-07-02 | Spyre Therapeutics, Inc. (SYRE) | Chief Financial Officer | 卖出 | 1,725 | $152,438 |
| 2026-06-26 | Spyre Therapeutics, Inc. (SYRE) | Chief Financial Officer | 买入 | 15,000 | $217,500 |
| 2026-06-26 | Spyre Therapeutics, Inc. (SYRE) | Chief Financial Officer | 卖出 | 5,000 | $435,600 |
| 2026-06-26 | Spyre Therapeutics, Inc. (SYRE) | Chief Financial Officer | 卖出 | 10,000 | $871,400 |
| 2026-06-03 | Spyre Therapeutics, Inc. (SYRE) | Chief Financial Officer | 买入 | 7,500 | $108,750 |
来源：SEC Form 4 申报文件 · 截至 2026-10-02